0000899243-21-024126.txt : 20210616 0000899243-21-024126.hdr.sgml : 20210616 20210616160520 ACCESSION NUMBER: 0000899243-21-024126 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210528 FILED AS OF DATE: 20210616 DATE AS OF CHANGE: 20210616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOWEN MAXINE CENTRAL INDEX KEY: 0001280044 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37773 FILM NUMBER: 211021510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merus N.V. CENTRAL INDEX KEY: 0001651311 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM BUSINESS PHONE: 31 030 253 8800 MAIL ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM FORMER COMPANY: FORMER CONFORMED NAME: Merus B.V. DATE OF NAME CHANGE: 20150819 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-05-28 2021-06-02 0 0001651311 Merus N.V. MRUS 0001280044 GOWEN MAXINE C/O MERUS N.V. YALELAAN 62 UTRETCHT P7 3584 CM NETHERLANDS 1 0 0 0 Share option (right to buy) 21.15 2021-05-28 4 A 0 12240 0.00 A 2031-05-28 Common Shares 12240 12240 D Options vest as to 33% on May 28, 2022 and as to 1/24th monthly thereafter, subject to the non-executive director continuing in service as a non-executive director through each such vesting date. Due to an administrative error, the vesting information shown on the Reporting Person's Form 4 filed on June 2, 2021 was incorrect; the vesting terms have been corrected in the "Explanation of Responses" above. The remainder of the information contained in the June 2, 2021 Form 4 was correct and has been re-reported in this amendment for administrative purposes only. This amended Form 4 is intended only to correct the vesting schedule as noted above; all other information remains identical to the June 2, 2021 filing. /s/ Peter Silverman as attorney-in-fact 2021-06-16